As the situation continues to unfold, president Donald Trump on Thursday named Medicare director and earlier health care executive Chris Klomp to be deputy secretary of the US Department of Health and Human Services. The deputy secretary oversees operations and regulatory policy. Officials are expected to release further statements.

Key Plays

Several key factors have contributed to the current state of affairs.

The move would make Klomp second in command behind HHS Secretary Robert F. Kennedy Jr., whom he has been closely advising for several months.

“ HHS is a massive and complex organization, but Chris knows exactly how to run it, ” Trump said in a post on Truth Social.

Further developments have shed additional light on the matter. he added that he, Kennedy and Centers for Medicare & Medicaid Services Administrator Dr. Mehmet Oz “ made this ruling together! ” Klomp would need to be validated by the Senate as deputy secretary, adding his name to a list of federal health nominees awaiting hearings before the Senate Health, Education, Labor and Pensions Committee.

Top Performers

Specialists in the field say the implications extend further than initially apparent.

HHS has been without a deputy secretary since Jim O ’ Neill left in February as part of a broader shakeup in agency leadership, partly in an initiative to refocus health care messaging around lower costs and the TrumpRx program, people familiar advised CNN at the time.

Notably, that same month, Klomp, who had been serving as Medicare director since April 2025, was chosen to oversee HHS operations and advise Kennedy.

Alongside the primary story, as Medicare ’ s chief, Klomp became a fixture in the administration ’ s efforts to broker TrumpRx deals with pharmaceutical companies and build Trump ’ s most-favored nations plan to further cut prescription drug costs.

The Stats

Looking at the practical effects, the outlook remains significant and wide-ranging.

“ Chris Klomp has been unbelievable, a real star, ” Trump said during a White House event in April touting a deal with drugmaker Regeneron.

Alongside the primary story, “ You don ’ t know his name as much as some of the others, but he ’ s a real star of the group. ” At HHS, Klomp led the searches this year for candidates to lead the US Centers for Disease Control and Prevention and the surgeon general ’ s office.

Further developments have shed additional light on the matter. in April, Trump nominated public health veteran Dr. Erica Schwartz for CDC director and Fox News contributor Dr. Nicole Saphier for surgeon general; both await Senate confirmation hearings.

Observers have also noted that klomp has also been closely involved in the search for a replacement for former US Food and Drug Administration Commissioner Dr. Marty Makary, who stepped down in May.

Next Up

The situation is far from resolved, and additional details are expected to emerge as the story develops. Officials have indicated that further statements may be forthcoming, and observers will be watching closely.